GreenLight Biosciences (GRNAW) Stock Analysis

What GreenLight Biosciences does

GreenLight Biosciences Holdings operates as a biotechnology enterprise, focusing on the development and commercialization of ribonucleic acid (RNA) products. These innovative solutions cater to both human medical needs and agricultural applications. The company's offerings for human well-being include mRNA-based vaccines and various therapeutic treatments. Within the agricultural domain, they provide RNA-driven products engineered to defend honeybee populations and safeguard cultivated crops. Established in 2008, GreenLight Biosciences Holdings maintains its corporate headquarters in Medford, Massachusetts.

Key metrics

ETFs linked to GRNAW

Broad-market and Healthcare sector ETFs an investor holding GreenLight Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRNAW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for GreenLight Biosciences?

GreenLight Biosciences trades under the ticker GRNAW on NASDAQ.

Which exchange is GRNAW listed on?

GRNAW is listed on NASDAQ.

What sector does GreenLight Biosciences operate in?

GreenLight Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GRNAW in a portfolio?

PortView shows GRNAW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.